Literature DB >> 3428864

In vitro insulin-like actions of human growth hormone: a study with an insulin antibody.

L G Frigeri1, K Teguh, U J Lewis.   

Abstract

When polyclonal insulin antibodies were preincubated with either adipose tissue from hypophysectomized rats or adipocytes from normal rats, human growth hormone failed to stimulate glucose oxidation. Removal of insulin from adipocytes through incubation with pyruvate at pH 7.0, followed by washing three times, also abolished subsequent in vitro insulin-like action of hGH. Administration of the same insulin antibody to hypophysectomized rats 30 minutes prior to injection of hGH did not inhibit the insulin-like activity of the hGH as measured by its ability to decrease serum glucose and non-esterified fatty acid levels. It is concluded that the in vitro promotion of glucose oxidation by hGH requires insulin. Because of the uncertainty of complete removal of insulin in intact animals, such a conclusion cannot be made regarding in vivo insulin-like action of hGH.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3428864     DOI: 10.1055/s-2007-1011854

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

1.  Contribution of hGH20K variant to blood hGH response in sauna and exercise.

Authors:  S Doré; G R Brisson; A Fournier; R Montpetit; H Perrault; D Boisvert
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

Review 2.  Resolving genetic heterogeneity in cancer.

Authors:  Samra Turajlic; Andrea Sottoriva; Trevor Graham; Charles Swanton
Journal:  Nat Rev Genet       Date:  2019-07       Impact factor: 53.242

Review 3.  Tumor propagating cells: drivers of tumor plasticity, heterogeneity, and recurrence.

Authors:  Alexandre Teixeira Vessoni; Eduardo Cremonese Filippi-Chiela; Guido Lenz; Luis Francisco Zirnberger Batista
Journal:  Oncogene       Date:  2019-12-04       Impact factor: 9.867

4.  Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity.

Authors:  Tanya N Phung; Timothy H Webster; Elizabeth Lenkiewicz; Smriti Malasi; Mariacarla Andreozzi; Ann E McCullough; Karen S Anderson; Barbara A Pockaj; Melissa A Wilson; Michael T Barrett
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

5.  Treatment scheduling effects on the evolution of drug resistance in heterogeneous cancer cell populations.

Authors:  Gauri A Patwardhan; Michal Marczyk; Vikram B Wali; David F Stern; Lajos Pusztai; Christos Hatzis
Journal:  NPJ Breast Cancer       Date:  2021-05-26

6.  Population dynamics of normal human blood inferred from somatic mutations.

Authors:  Henry Lee-Six; Nina Friesgaard Øbro; Mairi S Shepherd; Sebastian Grossmann; Kevin Dawson; Miriam Belmonte; Robert J Osborne; Brian J P Huntly; Inigo Martincorena; Elizabeth Anderson; Laura O'Neill; Michael R Stratton; Elisa Laurenti; Anthony R Green; David G Kent; Peter J Campbell
Journal:  Nature       Date:  2018-09-05       Impact factor: 49.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.